169 results on '"CTI Bont"'
Search Results
2. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study
3. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study
4. Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality
5. Outpatient respiratory syncytial virus infections and novel preventive interventions
6. Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
7. External Validation of the Discriminative Validity of the ReSVinet Score and Development of Simplified ReSVinet Scores in Secondary Care
8. Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines
9. Validity of clinical severity scores for respiratory syncytial virus: a systematic review
10. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes
11. Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial
12. Targeting respiratory syncytial virus vaccination using individual prediction
13. Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study
14. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection
15. Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis
16. Biobanking and consenting to research: a qualitative thematic analysis of young people’s perspectives in the North East of England
17. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
18. Adeno-associated virus 2 infection in children with non-A–E hepatitis
19. Lethal Respiratory Syncytial Virus in Zambia Is Sensitive to Long-acting Monoclonal Antibodies
20. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
21. Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
22. Are maternal vaccines effective and safe for mothers and infants?: A systematic review and meta-analysis of randomised controlled trials
23. Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
24. Respiratory syncytial virus infection and novel interventions
25. Genomic investigations of unexplained acute hepatitis in children
26. Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin
27. Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study
28. Bacterial Colonization of the Lower Airways in Children With Esophageal Atresia
29. Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
30. Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries
31. RSV immunisation: lessons from the COVID-19 pandemic
32. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
33. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe
34. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
35. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
36. Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series
37. Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients
38. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
39. Quantifying the RSV immunity debt following COVID-19: a public health matter
40. Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage
41. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
42. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study
43. Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
44. Differential isoform expression of Allergin-1 during acute and chronic inflammation
45. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic
46. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures
47. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
48. SOCIAL LISTENING AND GOOGLE TRENDS AS TOOLS FOR ESTIMATING PUBLIC AWARENESS OF RESPIRATORY SYNCYTIAL VIRUS
49. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome
50. Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.